Drug Filter >
  • 靶点: B cell lymphoma-2 (Bcl-2)
  •   > 
Drug Filter
Status:
Approved (1) NDA Filing (1) Phase Ⅲ (1) Phase Ⅱ (5) Phase Ⅰ (3) IND Filing (2)
Clinical Stage:
Pending (1) Active (7) Discontinued (3)
Company:
Abbvie (3) Ascentage Pharma (2) Ascenta (1) Beijing Fengshuo Weikang (1) Daiichi Sankyo (1) Fujian Jinshon Biologicalpharmaceutical (1) Genta (1) M.D. Anderson Cancer Center (1) National Cancer Institute (1) Novartis (1) ProNAi (1) Sanofi (1) Servier (1) Teva (1) Tolero Pharmaceuticals (1) Vernalis (1) 未知 (0)
Indication:
Acute myeloid Leukemia (AML) (2) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (4) Follicular lymphoma (1) Gastric cancer (2) Lung cancer (1) Lymphoma (1) Malignancies (1) Mantle cell lymphoma (MCL) (2) Melanoma (2) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Myeloid leukemia (1) Non small cell lung cancer (NSCLC) (5) Non-Hodgkin’s lymphoma (NHL) (5) Ovarian cancer (2) Prostate cancer (3) Solid tumours (2) Diffuse large B cell lymphoma (1) Liver cancer (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:

CopyRight©2017药渡经纬信息科技(北京)有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码